Irvine-based Masimo (Nasdaq: MASI) invested in Würzberg, Gemany-based TNI Medical AG.

Masimo makes patient monitoring equipment; TNI’s technology provides high-flow humidified air to patients with pulmonary disease.

Masimo has backed research projects and Chief Executive Joe Kiani has invested in start-ups. It traded recently at an $8 billion market cap, up 48% year-to-date.